tirzepatide compounding deadline 🚨 FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these Trimi GLP-1 Review 2026: What

372 Allopurinol, categorized as a purine-like XO inhibitor, and febuxostat and topiroxostat, classified as non-purine XO inhibitors, constitute the primary pharmacological approach for ULT

Using a large multicenter real-world dataset, we assessed clinical pregnancy, live birth, and time-to-event outcomes across body mass index subgroups to inform the reproductive safety profile of semaglutide and guide preconception counseling

Gallup reports that US obesity rates have been declining since 2022 in a trend that aligns with the rising popularity of glucagon-like peptide-1 (GLP-1) treatment

Healthcare providers should counsel patients that while these medications are legal prescription drugs in the United States, their regulatory status varies significantly worldwide, and some countries may have restrictions or require additional documentation for entry